Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors

This publication has 24 references indexed in Scilit:

• Identification and sequence of an accessory factor required for activation of the human interferon γ receptor
  Cell, 1994
• Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?
  Immunology Today, 1994
• Prevention of Runting and Cachexia by a Chimeric TNF Receptor-Fc Protein
  Clinical Immunology and Immunopathology, 1993
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
  The Journal of Experimental Medicine, 1993
• New strategies for active immunotherapy with genetically engineered tumor cells
  Current Opinion in Immunology, 1992
• Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors
  Cellular Immunology, 1991
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990
• RELATIONSHIP BETWEEN INDUCIBLE H-2 EXPRESSION AND THE IMMUNOGENICITY OF MURINE SKIN NEOPLASMS
  Transplantation, 1989
• The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
  The Journal of Experimental Medicine, 1988
• Tumor Necrosis Factor (TNF)
  Science, 1985